Profile and variability of intraocular pressure after the EX-PRESS device implant

Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.

Saved in:
Bibliographic Details
Main Authors: Silva,Rodrigo Egidio da, Jácomo,Juliana de Lima, Vilela,Lara Ribeiro, Oliveira,Antônio Wilson Soares de, Rodrigues,Francisco Wellington
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Oftalmologia 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-72802019000600364
record_format ojs
spelling oai:scielo:S0034-728020190006003642019-11-27Profile and variability of intraocular pressure after the EX-PRESS device implantSilva,Rodrigo Egidio daJácomo,Juliana de LimaVilela,Lara RibeiroOliveira,Antônio Wilson Soares deRodrigues,Francisco Wellington Glaucoma drainage implants Glaucoma Intraocular pressure Drug therapy Postoperative complications Prosthesis implantation/methods Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.info:eu-repo/semantics/openAccessSociedade Brasileira de OftalmologiaRevista Brasileira de Oftalmologia v.78 n.6 20192019-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364en10.5935/0034-7280.20190162
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Silva,Rodrigo Egidio da
Jácomo,Juliana de Lima
Vilela,Lara Ribeiro
Oliveira,Antônio Wilson Soares de
Rodrigues,Francisco Wellington
spellingShingle Silva,Rodrigo Egidio da
Jácomo,Juliana de Lima
Vilela,Lara Ribeiro
Oliveira,Antônio Wilson Soares de
Rodrigues,Francisco Wellington
Profile and variability of intraocular pressure after the EX-PRESS device implant
author_facet Silva,Rodrigo Egidio da
Jácomo,Juliana de Lima
Vilela,Lara Ribeiro
Oliveira,Antônio Wilson Soares de
Rodrigues,Francisco Wellington
author_sort Silva,Rodrigo Egidio da
title Profile and variability of intraocular pressure after the EX-PRESS device implant
title_short Profile and variability of intraocular pressure after the EX-PRESS device implant
title_full Profile and variability of intraocular pressure after the EX-PRESS device implant
title_fullStr Profile and variability of intraocular pressure after the EX-PRESS device implant
title_full_unstemmed Profile and variability of intraocular pressure after the EX-PRESS device implant
title_sort profile and variability of intraocular pressure after the ex-press device implant
description Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.
publisher Sociedade Brasileira de Oftalmologia
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364
work_keys_str_mv AT silvarodrigoegidioda profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant
AT jacomojulianadelima profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant
AT vilelalararibeiro profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant
AT oliveiraantoniowilsonsoaresde profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant
AT rodriguesfranciscowellington profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant
_version_ 1756377511235682304